AIMS To evaluate the efficacy of amniotic membrane transplantation (AMT) in persistent corneal epithelial defect with or without stromal thinning and corneal perforation.
METHODS 28 patients (28 eyes) with persistent corneal epithelial defect unresponsive to medical treatment were given preserved human amniotic membrane transplants. The patients were divided into three groups: group A, persistent corneal epithelial defect 10 eyes; group B, epithelial defect with stromal thinning 13 eyes; and group C, corneal perforation five eyes. AMT was performed using one layer in group A and multilayers in group B and C. The causes of persistent epithelial defect were neurotrophic keratopathy (24 eyes), limbal deficiency (six eyes), exposure keratopathy (four eyes), and Mooren's ulcer (one eye).
RESULTS Success was noted in 82.1% (23/28 eyes) in all groups, with 80% (8/10 eyes), 84.6% (11/13 eyes), and 80% (4/5 eyes) in groups A, B, and C respectively, with a mean follow up of 10.9 months (1–30 months). The mean epithelialisation time after AMT was 2.1 weeks. The healing times of groups B and C are also significantly shorter than group A (p=0.017 and 0.018, respectively). Corneal stromal thickness was significantly increased in all cases in groups B and C (p=0.006). Those with corneal perforation in group C were completely healed by multilayer AMT. There was no difference in the epithelialisation time between successful cases treated by a single operation (17 eyes) or repeated operation (six eyes). Vision improved in 18.9% (8/28 eyes) and worsened as a result of cataract formation in 2.3% (1/28 eyes). Failure was noted in 17.9% (5/28 eyes), because of corneal infection (two eyes), neurotrophic keratopathy with and without limbal deficiency (two eyes), and intractable corneal perforation (one eye). No patient developed major immediate postoperative complications or graft rejection.
CONCLUSION Amniotic membrane can successfully treat refractory corneal epithelial defect by promoting epithelial healing and thus prevent corneal perforation. It can be used as a treatment for corneal perforation by restoring corneal stromal thickness so that emergency penetrating keratoplasty can be avoided.
- amniotic membrane transplantation
- corneal epithelial defect
- stromal thinning
Statistics from Altmetric.com
An intact corneal epithelium is one of the most important factors in maintaining ocular surface health. Corneal epithelial defects usually heal without any complications by a rapid proliferation of epithelial cells. During the process, several factors, such as chemical injuries from topical medications, mechanical insults from lid abnormalities, xerosis and trauma, and a deprivation of sensory innervation—that is, a neurotrophic keratopathy, can interfere with wound healing, leading to a condition called persistent epithelial defect (PED).1 Once PED occurs and is left unattended, Dellen's ulcer, corneal melting, descemetocele, and corneal perforation can subsequently develop, leading to a devastating condition and loss of sight.2 Traditional treatment for PED includes correcting the underlying condition, suppressing the inflammation, and promoting the healing process. Current treatments include tears, lubricants, fibronectin,3 4 growth factors,5 and substance P.6 However, if the defect persists even after the application of these treatments and stromal ulcer and thinning develop, surgical treatment such as tissue adhesive,7 contact lens,8 conjunctival flap,9 and tarsorrhaphy10 are often tried. Once a corneal perforation occurs application of glue and/or a penetrating keratoplasty is usually performed to restore the globe integrity. Nevertheless, these treatments are not without problems—for example, decreased vision and poor cosmesis with a conjunctival flap and tarsorrhaphy, tissue inflammation from glue toxicity, and an inadequacy of donated corneas in some countries.
In 1997, Lee and Tseng first introduced the use of amniotic membrane in the treatment of PED with corneal ulcer.11 The membrane has been used successfully to treat PED and ulcers from different causes. The procedure has been shown to promote epithelial healing, reduce vascularisation, yield a good cosmesis, and also to be relatively easy to perform. Kruse et al 12 also reported a rapid healing of the epithelial defect with an increase in stromal thickness after multilayer amniotic membrane transplantation (AMT) for deep corneal ulcers. Recently, Tseng and colleagues reported their success in using amniotic membrane (single and multilayer as a graft and patch) in persistent and progressive neurotrophic corneal ulcers. It has not been reported, but would be interesting to know the difference in corneal healing using a single layer of membrane and a multilayer method in PED and PED with stromal thinning and/or perforation. To answer these questions, we summarise our experience in using AMT for PED with and without corneal thinning, descemetocele, and perforation.
Patients and methods
This study was approved by the committee for the protection of human subjects in research, a part of the faculty of medicine at Siriraj Hospital, in Bangkok, Thailand. Between September 1997 and December 2000, 42 AMTs were performed on 28 patients (28 eyes). Written informed consent was obtained from each patient. Criteria for recruitment were persistent corneal epithelial defect that failed to respond to conventional treatments, PED with descemetocele or stromal thinning, and PED with a corneal perforation smaller than 1 mm in diameter with positive Seidel test. All patients were referred by different ophthalmologists after conventional treatments had been tried without success. The patients were divided into three groups—group A, PED without stromal thinning (10 eyes in 10 patients; see Fig 1); group B, PED with stromal thinning or descemetocele (13 eyes in 13 patients; see Fig 2); and group C, PED with corneal perforations (five eyes in five patients; see Fig 3). Surgical success was defined as complete epithelialisation of the ocular surface at the operated site as demonstrated by biomicroscopy and negative fluorescein staining without recurrence at the same area within 1 month after healing. In cases with corneal perforation (group C) surgical success also includes cessation of aqueous leakage and formation of a deep anterior chamber for at least 1 month postoperatively. Failure was defined as incomplete epithelialisation, persistence of the defect, or recurrence of an epithelial defect at the same site. In group C failure also included recurrence of aqueous leakage. Corneal thickness was evaluated using biomicroscopy before and after the operation at each visit. Stromal thickness at the thinning area (group B) or perforated site (group C) was recorded and compared with the thickness of the same area after the operation only when the surgical area was completely epithelialised. Increase in stromal thickness of the eye at the last follow up as seen by biomicroscopy and photography is defined as improvement of stromal thickness.
All patients had one or more underlying disease which predisposed to epithelial break down and PED—for example, neurotrophic keratopathy, limbal stem cell deficiency, exposure keratopathy, and Mooren's ulcer. Several associated conditions perpetuated the corneal epithelial defects such as severe keratoconjunctivitis sicca, bullous keratopathy, and keratouveitis. The demographic and clinical data are summarised in Tables 1 and2.
PREPARATION OF PRESERVED HUMAN AMNIOTIC MEMBRANE
Amniotic membranes obtained from the Bangkok Biomaterial Center were used for all patients in this study. Human amniotic membrane was prepared and preserved using a method previously described by Lee and Tseng11 with minor modification.14 The sheets of membranes were stored at −70°C for up to 1 year before use.
AMNIOTIC MEMBRANE TRANSPLANTATION, SURGICAL TECHNIQUE
All surgery was performed by one surgeon (PP). After retrobulbar or topical anaesthesia, amniotic membranes were placed using different techniques to cover the areas of defect in the recipient eyes. In group A (PED without stromal thinning) a single layer of membrane was used to cover the defect by trimming off the excess parts and was secured to the edge of the defect by interrupted or continuous 10–0 nylon suture with buried knots. The membrane was placed stromal side down (fig 1D). For group B (PED with stromal thinning) amniotic membranes were placed stromal side down, layer by layer, to fill up the ulcer and cover the defect. The layers were trimmed to fit the ulcer and the top layer was sutured as described above; the bottom layers were left unsutured (Fig2A). Two patients in group B underwent a single layer technique as in group A because of minimal stromal thinning. For group C, the bottom of a perforated site was covered by a small piece of amniotic membrane (AM) that fitted the size of the perforation and multilayer AM was then applied layer by layer to fill up the thinning area (Fig 3B). A larger piece of AM was placed uppermost to cover the whole defect area, trimmed to fit the ulcer, and sutured with an interrupted 10-0 nylon with an attempt to include a few layers of AM (Fig 3C). In some severe neurotrophic keratopathy cases, we performed a patch technique by applying an amniotic membrane over the whole cornea with the basement membrane side facing down, and sutured with 10-0 nylon as described. A bandage contact lens was applied on top of the membrane until the epithelial defect was completely healed.
POSTOPERATIVE EVALUATION AND FOLLOW UP
All patients received either topical 1% prednisolone acetate (Predforte, Allergan, Irvine, CA, USA) or non-preservative 1% methylprednisolone and 0.3% ciprofloxacin (Ciloxan, Alcon, Forte Worth, TX, USA) four times daily until complete epithelialisation was noted. After healing, topical antibiotics were discontinued and the topical steroid was tapered off.
Assessment of surgical outcome was determined by patients' symptoms (particularly pain, discomfort, and irritation), inflammation of the cornea and amniotic graft, healing time of the area covered by the membrane, corneal thickness, and cosmetic appearance. Fluorescein staining was used to detect epithelial defects. All patients were examined on postoperative day 1, then at the end of the first week, second week, and monthly thereafter. Corneal epithelial healing was further classified into success and failure.
The qualitative data were analysed by χ2 test. The quantitative preoperative and postoperative data were analysed by paired sample t tests for the parametric data and Wilcoxon sign rank test for non-parametric data. In independent non-parametric data, a Mann-Whitney U test was used to compare the two groups and Kruskal-Wallis H was used to compare more than two groups and ANOVA in parametric data. The data were analysed using spss version 9.0 with the assistance of the statistics unit of the department of ophthalmology, Siriraj Hospital. A p value of less than 0.05 was considered significant.
The mean age of these 28 patients (16 men and 12 women) was 48.7 years (range 5–86 years). Total mean follow up time was 10.9 (SD 6.9) months (range 1–30 months), and 12.8 (9.3) months (3–30 months), 10.9 (4.1) months (5–15 months), and 7.5 (7.6) months (1–20 months), in groups A, B, and C respectively (Table 1). The short follow up periods of less than 3 months in three cases (case 8 in group A, cases 1 and 4 in group C) were the result of concurrent procedures, such as penetrating keratoplasty (PKP) and limbal transplantation combined with PKP, which made observation of the corneal surface integrity after AMT no longer possible (Tables 1 and 2). However, the follow up times among these three groups were not statistically significant (p = 0.395 by ANOVA test).
After operation, final vision remained unchanged in 19 eyes (67.8%), improved in eight eyes (28.6%), and was lost in one eye because of severe uveitis. Among patients with improved vision, five cases (62.5%) gained more than 2 Snellen lines. However, because of the severe underlying diseases previously mntioned which led to PED and associated conditions such as glaucoma, cataract, uveitis, and optic neuropathy, the final postoperative visual acuity was limited to equal or worse than 6/60 in 23 cases (82.1%).
In all patients, conventional medical and surgical treatments to correct the underlying and associating conditions had been tried. Non-preservative artificial tears (18 cases) and punctal occlusion (seven cases) for sicca patients, applications of extended bandage lens (nine cases), pressure patching (six cases), and/or tarsorhaphy (three cases, Fig 1B, D, F) were performed in patients with exposure keratitis and neurotrophic ulcer (details are in Tables 1 and 2). Despite all the efforts, epithelial defects persisted for 6.9 (7.0) weeks (2–24 weeks) in group A and 4.0 (3.3) weeks (1–12 weeks) in group B. In group C, no conventional therapy had been tried because of corneal perforations which mandate to immediate surgery.
Single layer AMT was performed in group A (Fig 1D–F) and a multilayer method was performed in almost all patients with corneal thinning and/or perforation (groups B (Fig 2A) and C (Fig 3B, C)) to promote epithelial healing and restore corneal integrity. Glue had been used to fill the bottom of the perforated ulcer in one case (group C, Fig 3E, F) before placing multiple layers of the amniotic membrane. Some cases required repeated transplantation which will be discussed later.
The total success rate of epithelial healing was 82.1% (23 of 28 eyes), with 80% (eight of 10 eyes), 84.6% (11 of 13 eyes), and 80% (four of five eyes), in groups A, B, and C respectively. In terms of epithelialisation, the average sizes of corneal epithelial defect in each group before the surgeries were not significantly different (3.9, 3.5, and 4.3 mm in group A, B, and C respectively, p = 0.44). The total mean epithelialisation time after AMT was 2.1 (SD 1.9) weeks (range 0.5–8 weeks), with 3.5 (2.6) weeks in group A, 1.5 (1.0) weeks in group B and 1.1 (0.5) weeks in group C. Among these three groups, epithelial defects in groups B and C healed more rapidly than those in group A (p = 0.003, p = 0.017, and p = 0.009) (Table3).
Among the successful cases, all but three (89.3 %) healed within 4 weeks. The cases with delayed healing were a case of partial limbal deficiency from Stevens-Johnson syndrome which took 6 weeks to heal, an undetected severe dry eye patient who healed rapidly within a week after punctal occlusion was additionally performed, and a case of severe neurotrophic keratopathy which required 8 weeks to recover.
Regarding the techniques performed, epithelial defects of the patients who underwent multilayer AMT healed significantly faster than those who underwent a single layer method (p = 0.014). The stromal thickness of the patients with corneal stromal thinning and/or perforation (groups B and C) also significantly increased at the end of the follow up (p = 0.022, Table 3). These statistically significant findings might relate to the multilayer method AMT used in groups B and C, which will be discussed later.
Most of the patients already had limited visual acuity due to their corneal abnormalities, thus the slight opacification of the amniotic membrane during the first few weeks did not cause their vision to deteriorate further. Furthermore, the membrane became gradually transparent and the healing area became clearer, similar to the adjacent area. Interestingly, the amniotic membrane in group A persisted longer than that in group B and C (Table 3). However, 66% of the amniotic membrane dissolved before 3 months.
Ten cases required repeated AMT, four were failed cases and six were successful cases. Repeated operations were required in the six successful cases because of new epithelial defects that occurred at the different site after the initial ones were healed (four cases). Those are cases with lid abnormality (Fig 1A, B), post-radiation, and severe neurotrophic keratopathy. One successful case required repeated AMT due to glue removal after the defect was completely healed (Fig 3E–H), the other from graft lost (case 6 in group B, Table 2). Among all the successful cases that underwent repeated AMT, the epithelial healing time in patients who had single transplantation was not different from those underwent multiple transplantations.
Failure was noted in five cases (17.8%) in this study, two from undetected active infection, two from severe neurotrophic keratopathy with and without limbal deficiency, and one had intractable corneal perforation. Among the two infected cases, one eye had an occult fungal corneal ulcer at the time of AMT and the other eye developed geographic herpetic ulcer after AMT. Infection in both cases responded well to medical treatment but the defects persisted. Four of these five failed cases underwent repeated AMT without success.
The basic principles for treating PED can be summarised as follows: firstly, correction of mechanical insults such as lid abnormality and exposure. Secondly, surface healing should be promoted by punctal occlusion and artificial tears,15 application of growth factors,5 and substance P.6Thirdly, inflammation should be suppressed by using topical steroids and antiproteolytic substances.16 17
Amniotic membranes have been widely used in ophthalmology: as a graft and patch for conjunctival reconstruction,18-21 corneal surface reconstruction,11-14 20-24 forniceal reconstruction,18 and glaucoma surgery.25 The membrane possesses several properties that serve all basic principles for managing PED. It acts as a biological bandage lens to prevent mechanical trauma from lids, prevent exposure, and reduce surface dryness. Amniotic membrane has been reported by several investigators to promote ocular surface healing and can be successfully used in PED.11-13 Our study not only supports the idea that AMT can be considered as an effective therapy for treating PED but also demonstrated that this procedure is effective in treating corneal perforation associated with PED. The success rates are some 80% in total (80%, 84.6%, and 80% in groups A, B, and C respectively), regardless of stromal thickness. The epithelialisation times were also shorter after AMT. This finding might be explained by the fact that amniotic membrane provides a thick basement membrane to facilitate epithelial migration and reinforces the adhesion of basal epithelial cells26 27 causing rapid epithelialisation. It also promotes epithelial differentiation and prevents epithelial apoptosis.28 29 A recent study also shows that preserved AM expresses mRNAs for several growth factors and contains a number of growth factor proteins that might benefit epithelialisation.30 In this study, we reported the efficacy of AMT alone (three cases) and combined treatment with glue (one case) in treating small corneal perforations, while Su and Lin31 previously reported a satisfactory result of combined glue and amniotic membrane in a case of corneal perforation, using a different technique.
Among the three groups in our study, with no different of epithelial defect size before the surgeries (p = 0.44), epithelial defects in groups B (PED with stromal thinning) and C (with perforation) healed more rapidly than those in group A (p = 0.017 and 0.009). Regarding the techniques performed, patients with multilayer AMT healed faster than those with a single layer. This difference was statistically significant (p = 0.014). Since most of the patients in groups B and C underwent multilayer AMT while patients in group A received a single layer technique, we relate these findings to the aforementioned studies which suggest that the amniotic membrane matrix provided the growth factors needed for epithelial healing. It is possible that the more amniotic membrane matrix placed on the ulcer, the faster the wound healing.
Interestingly, corneal stromal thickness in this study (groups B (Fig2C, F) and C (Fig 3A, D)) can be significantly restored in all cases (p = 0.022). This finding is consistent with the study of Kruse12 and might be explained by his hypothesis that AM might be able to modify the proliferation and migration of stromal fibroblasts. It should be noted that a cornea with a perforated ulcer can recover to normal or near normal thickness with a significant amount of stromal keratocytes as shown in the pathological section (Fig3H). Furthermore, the rate of amniotic membrane dissolution is faster in groups B and C compared with group A. It is possible that with a stromal ulcer, the inflammatory cytokines and proteolytic enzymes released by stromal keratocytes and inflammatory cells are more abundant thus inducing more rapid membrane dissolution.
In this study, ocular surface inflammation was markedly reduced after AMT, which has been reported previously by several investigators.11-13 This may be explained by studies showing that the stromal matrix of the amniotic membrane excludes inflammatory cells,32 contains protease inhibitors33 and anti-inflammatory protein,34suppresses TGF-β signalling and proliferation, and myofibroblast differentiation of human corneal and limbal fibroblasts.35 36
Failure was noted in five cases (17.8%) in this study, two from undetected active infection, two from severe neurotrophic keratopathy with and without limbal deficiency, and one had an intractable corneal perforation. These failures point out the limitations of AMT in treating PED. Firstly, continuous tissue destruction can be anticipated with active infection underneath the graft and this will retard healing. Secondly, adequate limbal stem cells and intact sensory innervation are mandatory for repairing and maintaining the ocular surface integrity.13 Thirdly, normal keratocytes from the adjacent area might be important in restoring stromal integrity after AMT, as demonstrated in one of our failed cases in which a perforation occurred at the centre of the scarred area. A multilayer AMT was performed without success, presumably because of the lack of healthy keratocytes needed for wound healing.
An amniotic membrane graft possesses many advantages over a conjunctival graft. The membrane usually becomes transparent after a few weeks causing no deterioration in visual acuity. Unlike a conjunctival flap or graft, the cornea covered by amniotic membrane will develop less vascularisation and is more acceptable in term of cosmesis. Furthermore, unnecessary trauma at the donor site can be avoided by using an amniotic graft, leaving a healthy conjunctiva for future surgery.
Lee and Tseng11 first demonstrated the efficacy of AM in treating PED from various causes while Kruse12successfully introduced the use of multilayer AMT for deep corneal ulcer. In this study, we reported the results of AMT for a variety of corneal ulcer, using single and multilayer technique. We have demonstrated that AMT is an effective treatment for PED and PED with deep ulcer, descemetocele, and perforation. Performing multilayer AMT can successfully manage small corneal perforations and convert emergency tectonic PKP into elective optical PKP which is a more favourable procedure with a better outcome for vision. The use of AMT in treating PED with deep ulcer and perforation might even eliminate the need for PKP in some cases and is therefore beneficial in the countries where cornea shortage is apparent. The technique is simple and produces no additional serious adverse effect to the patients. We therefore encourage the use of AMT in simple and complicated PED. However, there is no established consensus regarding the optimal time to perform AMT in corneal epithelial defects. Should the method be delayed until all conventional treatments fail or be considered earlier? We recognise that our series is relatively small and a larger, randomised, controlled study may be needed to answer all these questions.
The authors wish to thank the Bangkok Biomaterial Center for preparing and providing the amniotic membrane, the Department of Obstetrics and Gynecology, Siriraj Hospital, for helpful cooperation in obtaining the placenta, associate professor Thaivadee Dulayajinda and associate professor Panida Kosrisukvongs for their helpful advice.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.